Oaktree Acquisition Corp. III Life Sciences (OACC) posts $3.0M H1 2026 income
Oaktree Acquisition Corp. III Life Sciences (OACC), a SPAC, reported a net income of $1.6 million for Q2 2026 and $3.0 million for H1 2026, primarily from interest on its $205.3 million Trust Account. The company faces a critical deadline of October 25, 2026, …